Literature DB >> 18354780

Proteasome modulators: essential chemical genetic tools for understanding human diseases.

Marie Wehenkel1, Jin Tae Hong, Kyung Bo Kim.   

Abstract

Primarily used for medicinal purposes in the past, biologically active small molecules have been increasingly employed to explore complex biological processes in the era of "chemical genetics". Since the contributions of this small molecule approach to biology have been extensive, we limit the focus of our review to the use of small-molecule modulators in the exciting field of proteasomal biology, one that has benefited significantly from a chemical genetics approach. Specifically, as the contributions of general inhibitors of proteasomal activity to the fields of cell biology and clinical oncology have been extensively discussed in several excellent reviews, we instead outline recent progress towards the development of novel, specific classes of proteasome modulators for studies of proteasomal biology and the types of proteasome inhibitors emerging as important new treatment options for cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354780     DOI: 10.1039/b716221a

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  4 in total

1.  Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells.

Authors:  Lalit Kumar Sharma; Na-Ra Lee; Eun Ryoung Jang; Beilei Lei; Chang-Guo Zhan; Wooin Lee; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2012-07-17       Impact factor: 3.164

2.  Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations.

Authors:  Beilei Lei; Mohamed Diwan M Abdul Hameed; Adel Hamza; Marie Wehenkel; Jennifer L Muzyka; Xiao-Jun Yao; Kyung-Bo Kim; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-09-30       Impact factor: 2.991

3.  Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.

Authors:  Michele Mishto; Elena Bellavista; Claudia Ligorio; Kathrin Textoris-Taube; Aurelia Santoro; Mara Giordano; Sandra D'Alfonso; Florinda Listì; Benedetta Nacmias; Elena Cellini; Maurizio Leone; Luigi M E Grimaldi; Chiara Fenoglio; Federica Esposito; Filippo Martinelli-Boneschi; Daniela Galimberti; Elio Scarpini; Ulrike Seifert; Maria Pia Amato; Calogero Caruso; Maria P Foschini; Peter M Kloetzel; Claudio Franceschi
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

4.  A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice.

Authors:  M Wehenkel; J-O Ban; Y-K Ho; K C Carmony; J T Hong; K B Kim
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.